Assessment of lymph nodes for micrometastasis in high risk patients with colorectal cancer

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter G. Botiralieva
Citation Annals of Oncology (2016) 27 (2): 1-85. 10.1093/annonc/mdw199
Authors G. Botiralieva1, D. Nishanov1, S. Navruzov2
  • 1National Cancer Research Centre, Tashkent, Uzbekistan, /
  • 2Russian Surgery Institute, Tashkent, Uzbekistan, /


Colorectal carcinoma (CRC) is one of the most common gastrointestinal malignancies in Uzbekistan, and the incidence continues to steadily increase. The prognosis for patients with colorectal cancer is represented by lymph node (LN) metastases. Approximately 42% of all colorectal cancer patients with histologically node-negative (N0) disease, within 5 years develop regional or distant metastases. The detection of disseminated tumor cells in the lymph nodes after curative resection could help to identify a patient subgroup at risk for disease relapse who could benefit from adjuvant therapy.